Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma

Dermatology Online Journal

Volumn 14, Issue 3, 2008, Pages

  Paternò, Evelin Jasmine ^a   Campione, Elena ^a   Diluvio, Laura ^a   Orlandi, Augusto ^a   Chimenti, Sergio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMIQUIMOD; PREDNISONE; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ADULT; ARTICLE; CASE REPORT; GLOMERULONEPHRITIS; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KERATOACANTHOMA; KIDNEY GRAFT REJECTION; MALE; MULTIPLE CANCER; PERSISTENT KERATOACANTHOMA; PUNCH BIOPSY; TREATMENT DURATION; TUMOR REGRESSION; IMMUNE DEFICIENCY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOLOGY; SKIN; SKIN TUMOR;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; HUMANS; IMMUNOCOMPROMISED HOST; KERATOACANTHOMA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SKIN; SKIN NEOPLASMS;

EID: 42549126474     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Goette DG, Odom RB. Successful treatment of keratoacanthoma with intralesional fluorouracil. J Am Acad Dermatol 1980; 2: 212-6.
2. Rosenblum GA. Multiple palmar keratoacanthomas treated with acitretin. J Drugs Dermatol. 2006 Nov-Dec;5(10):1006-9.
3. Andreassi A, Pianigiani E, Taddeucci P, Lorenzini G, Fimiani M, Biagioli M.Guess what! Keratoacanthoma treated with intralesional bleomycin. Eur J Dermatol. 1999 Jul-Aug;9(5):403-5
4. Melton JL, Nelson BR, Stough DB, Brown MD, Swanson NA, Johnson TM. Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol 1991; 25: 1017-23.
5. Santosa Pham JC, Shelley ED, Shelley WB. Aggressive giant keratoacanthoma of the face treated with intramuscular methotrexate and triamcinolone acetonide. Cutis 1997; 59: 329-32.
6. Donahue B, Cooper JS, Rush S. Treatment of aggressive keratoacanthomas by radiotherapy. J Am Acad Dermatol 1990; 23: 489-93.
7. Dendorfer M, Oppel T, Wollenberg A, Prinz JC. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol. 2003; 13: 80-2.
8. Batinac T, Zamolo G, Hadzisejdic I, Zauhar G. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma. J Dermatol Sci 2006; 44(2): 109-12.
9. Smith KJ, Hamza S, Skelton H. Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/ macrophage populations to a Th1 and M1 cytokine pattern. Clin Exp Dermatol. 2004; 29(5): 505-12.
10. Peris K, Micantonio T, Fargnoli MC. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream. Eur J Dermatol 2003; 44: 413-4.
11. De Melo MR Jr, Filho JL, Patu VJ, Machado MC, Mello LA, Carvalho LB Jr. Langerhans cells in cutaneous tumours: immunohistochemistry study using a computer image analysis system. J Mol Histol 2006 Nov;37(8-9):321-5. Epub 2006 Nov 2.
12. Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 2003; 139(10): 1325-32.
13. Berman B, Sullivan T, De Araujo T, Nadji M. Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. Br J Dermatol 2003; 149(Suppl.66): 59-61.
14. Barinaga M. Angiogeneses research. Cancer drugs found to work in new ways. Science 2000; 288: 245.
15. Ferrandiz C, Fuente MJ, Ribera M, Bielsa I, Fernandez MT, Lauzurica R, Roca J. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33: 590-6.
16. Smith KJ, Germain M, Skelton H. Squamous cell carcinoma in situ in renal transplant patients treated with 5% imiquimod and 5% 5 fluorouracil therapy. Dermatol Surg 2001; 27: 561-64.
17. Kovach BT, Stasko T. Use of topical immunomodulators in organ transplant recipients. Dermatol Ther 2005; 18(1): 19-27.